http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3079684-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7dde2cad3370a4faa139de79a435e7a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4813
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
filingDate 2014-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95da77675eb3eae4944a752994e9592e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_817fa11cb4bf1994a08ecbb9d17bd076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b2cb813f80b9ecd80c5ddf4b5a28055
publicationDate 2016-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3079684-A1
titleOfInvention Compositions and methods for the treatment of diseases related to the renin-angiotensin-system
abstract The present invention relates to a pharmaceutical composition comprising a. at least one aspartyl aminopeptidase inhibitor and at least one angiotensin- converting-enzyme (ACE) inhibitor, or b. at least one aspartyl aminopeptidase inhibitor and at least one chymase inhibitor. In an embodiment, the pharmaceutical composition comprises at least one aspartyl aminopeptidase inhibitor and at least one angiotensin-converting-enzyme (ACE) inhibitor and at least one chymase inhibitor. Furthermore, the invention relates to a pharmaceutical composition possessing inhibitory activity against a. aspartyl aminopeptidase and angiotensin-converting-enzyme (ACE), or b. against aspartyl aminopeptidase and chymase. In a third aspect, the invention relates to a kit of parts comprising a. a pharmaceutical composition comprising an aspartyl aminopeptidase inhibitor and a pharmaceutical composition comprising an angiotensin-converting-enzyme (ACE) inhibitor, or b. a pharmaceutical composition comprising an aspartyl aminopeptidase inhibitor and a pharmaceutical composition comprising a chymase inhibitor, or c. a pharmaceutical composition comprising an aspartyl aminopeptidase inhibitor and a pharmaceutical composition comprising an angiotensin-converting-enzyme (ACE) inhibitor and a pharmaceutical composition comprising a chymase inhibitor. The invention also relates to a method for decreasing the blood pressure in a subject by administering a therapeutically effective amount of a pharmaceutical composition according to the invention to the subject. In another aspect, the invention relates to a method for treating a disease related to the RAS in a subject by administering a therapeutically effective amount of a pharmaceutical composition according to the invention to the subject.
priorityDate 2013-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16051939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5463984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226492661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10351092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44364632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226785368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226785367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55891
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226485933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42104992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362119
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6916047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226522801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID189729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226522800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58666458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53766232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66586214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226526054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5484727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226547878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936189

Total number of triples: 99.